Table: Jcr Pharmaceuticals - 9-MTH group results

JCR Pharmaceuticals

31/01/2025 07:01

Jan 31 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               25.88               33.72            39.00    
                   (-23.2 pct)         (+26.3 pct)      (-9.0 pct)  
  Operating       loss 754 mln             7.81             1.40    
                                       (+57.7 pct)      (-81.4 pct) 
  Recurring         loss 1.38              7.39           750 mln   
                                       (+39.6 pct)      (-89.7 pct) 
  Net             loss 576 mln             5.16             2.20    
                                       (+44.6 pct)      (-60.1 pct) 
  EPS             loss 4.63 yen         41.35 yen        17.77 yen  
  EPS Diluted                           41.16 yen                   
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T